25 XP   0   0   10

Zhejiang Hisoar Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Hisoar together

PenkeI guess you are interested in Zhejiang Hisoar Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Hisoar Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Hisoar Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisoar Pharmaceutical Co Ltd.

Quick analysis of Hisoar (30 sec.)










What can you expect buying and holding a share of Hisoar? (30 sec.)

How much money do you get?

How much money do you get?
¥0.07
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.77
Expected worth in 1 year
¥3.75
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.46
Return On Investment
7.7%

For what price can you sell your share?

Current Price per Share
¥5.96
Expected price per share
¥3.91 - ¥6.5703
How sure are you?
50%

1. Valuation of Hisoar (5 min.)




Live pricePrice per Share (EOD)

¥5.96

Intrinsic Value Per Share

¥-3.51 - ¥1.83

Total Value Per Share

¥0.26 - ¥5.60

2. Growth of Hisoar (5 min.)




Is Hisoar growing?

Current yearPrevious yearGrowGrow %
How rich?$842.4m$843.6m-$1.2m-0.1%

How much money is Hisoar making?

Current yearPrevious yearGrowGrow %
Making money$12.1m$13.1m-$995.7k-8.2%
Net Profit Margin3.3%3.8%--

How much money comes from the company's main activities?

3. Financial Health of Hisoar (5 min.)




What can you expect buying and holding a share of Hisoar? (5 min.)

Welcome investor! Hisoar's management wants to use your money to grow the business. In return you get a share of Hisoar.

What can you expect buying and holding a share of Hisoar?

First you should know what it really means to hold a share of Hisoar. And how you can make/lose money.

Speculation

The Price per Share of Hisoar is ¥5.96. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hisoar.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hisoar, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.77. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hisoar.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.010.1%0.030.5%0.030.4%
Usd Book Value Change Per Share0.000.0%0.000.0%0.020.4%0.020.3%0.050.8%
Usd Dividend Per Share0.020.3%0.020.3%0.000.1%0.020.4%0.020.3%
Usd Total Gains Per Share0.020.3%0.020.3%0.030.5%0.040.7%0.061.1%
Usd Price Per Share0.97-0.97-1.14-0.98-1.22-
Price to Earnings Ratio128.93-128.93-140.06-67.81-76.11-
Price-to-Total Gains Ratio60.77-60.77-42.34-31.15-5.83-
Price to Book Ratio1.86-1.86-2.18-1.95-4.67-
Price-to-Total Gains Ratio60.77-60.77-42.34-31.15-5.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.82248
Number of shares1215
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.000.02
Usd Total Gains Per Share0.020.04
Gains per Quarter (1215 shares)19.3449.45
Gains per Year (1215 shares)77.37197.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
181-46711781188
2162-7144234161386
3243-11221352242584
4324-14298469322782
5405-18375586403980
6486-224527034831178
7567-255298215641376
8648-296069386441574
9729-3268310557251772
10810-3676011728061970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%19.00.01.095.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%18.02.00.090.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.02.090.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%19.01.00.095.0%

Fundamentals of Hisoar

About Zhejiang Hisoar Pharmaceutical Co Ltd

Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services. The company was founded in 1966 and is based in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-14 13:00:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hisoar earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.3% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 3.3%. The company is making a profit. +1
  • The TTM is 3.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY3.8%-0.6%
TTM3.3%5Y13.7%-10.4%
5Y13.7%10Y11.8%+1.9%
1.1.2. Return on Assets

Shows how efficient Hisoar is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.0% Return on Assets means that Hisoar generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.0%TTM1.0%0.0%
TTM1.0%YOY1.2%-0.1%
TTM1.0%5Y5.3%-4.3%
5Y5.3%10Y4.7%+0.7%
1.1.3. Return on Equity

Shows how efficient Hisoar is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.4% Return on Equity means Hisoar generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.4%0.0%
TTM1.4%YOY1.6%-0.1%
TTM1.4%5Y6.6%-5.2%
5Y6.6%10Y6.1%+0.6%

1.2. Operating Efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hisoar is operating .

  • Measures how much profit Hisoar makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 3.3% means the company generated ¥0.03  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 3.3%. The company is operating less efficient.
  • The TTM is 3.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY4.7%-1.4%
TTM3.3%5Y15.8%-12.5%
5Y15.8%10Y14.9%+0.9%
1.2.2. Operating Ratio

Measures how efficient Hisoar is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are ¥1.68 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.678. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.678. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.678TTM1.6780.000
TTM1.678YOY1.565+0.113
TTM1.6785Y1.419+0.259
5Y1.41910Y1.247+0.172

1.3. Liquidity of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hisoar is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.65 means the company has ¥1.65 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.647. The company is able to pay all its short-term debts. +1
  • The TTM is 1.647. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.647TTM1.6470.000
TTM1.647YOY1.984-0.337
TTM1.6475Y2.399-0.752
5Y2.39910Y1.820+0.578
1.3.2. Quick Ratio

Measures if Hisoar is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.253. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.253. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.2530.000
TTM0.253YOY0.339-0.086
TTM0.2535Y0.399-0.146
5Y0.39910Y0.368+0.032

1.4. Solvency of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hisoar assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hisoar to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Hisoar assets are financed with 27.3% credit (debt) and the remaining percentage (100% - 27.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.273. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.273. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.273TTM0.2730.000
TTM0.273YOY0.238+0.035
TTM0.2735Y0.216+0.057
5Y0.21610Y0.290-0.074
1.4.2. Debt to Equity Ratio

Measures if Hisoar is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 37.5% means that company has ¥0.37 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.375. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.375. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.375TTM0.3750.000
TTM0.375YOY0.312+0.063
TTM0.3755Y0.279+0.095
5Y0.27910Y0.533-0.253

2. Market Valuation of Zhejiang Hisoar Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hisoar generates.

  • Above 15 is considered overpriced but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 128.93 means the investor is paying ¥128.93 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is 109.614. Based on the earnings, the company is expensive. -2
  • The MRQ is 128.926. Based on the earnings, the company is expensive. -2
  • The TTM is 128.926. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD109.614MRQ128.926-19.311
MRQ128.926TTM128.9260.000
TTM128.926YOY140.064-11.138
TTM128.9265Y67.814+61.111
5Y67.81410Y76.110-8.296
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is -152.336. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -179.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -179.174. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-152.336MRQ-179.174+26.838
MRQ-179.174TTM-179.1740.000
TTM-179.174YOY-104.861-74.312
TTM-179.1745Y-42.986-136.187
5Y-42.98610Y40.951-83.937
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hisoar is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is 1.580. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.859. Based on the equity, the company is underpriced. +1
  • The TTM is 1.859. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.580MRQ1.859-0.278
MRQ1.859TTM1.8590.000
TTM1.859YOY2.182-0.323
TTM1.8595Y1.952-0.094
5Y1.95210Y4.674-2.722
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Hisoar Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.005-0.0050%0.162-103%0.120-104%0.332-102%
Book Value Per Share--3.7713.7710%3.7770%3.606+5%2.871+31%
Current Ratio--1.6471.6470%1.984-17%2.399-31%1.820-10%
Debt To Asset Ratio--0.2730.2730%0.238+15%0.216+26%0.290-6%
Debt To Equity Ratio--0.3750.3750%0.312+20%0.279+34%0.533-30%
Dividend Per Share--0.1210.1210%0.033+266%0.175-31%0.123-2%
Eps--0.0540.0540%0.059-8%0.232-77%0.186-71%
Free Cash Flow Per Share---0.039-0.0390%-0.079+101%0.155-125%0.104-138%
Free Cash Flow To Equity Per Share---0.114-0.1140%-0.029-75%-0.075-35%0.082-239%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--1.830--------
Intrinsic Value_10Y_min---3.513--------
Intrinsic Value_1Y_max--0.162--------
Intrinsic Value_1Y_min---0.048--------
Intrinsic Value_3Y_max--0.502--------
Intrinsic Value_3Y_min---0.408--------
Intrinsic Value_5Y_max--0.863--------
Intrinsic Value_5Y_min---1.055--------
Market Cap9647571200.000-18%11347227200.00011347227200.0000%13338252800.000-15%11457390788.712-1%14367855880.590-21%
Net Profit Margin--0.0330.0330%0.038-15%0.137-76%0.118-72%
Operating Margin--0.0330.0330%0.047-31%0.158-79%0.149-78%
Operating Ratio--1.6781.6780%1.565+7%1.419+18%1.247+35%
Pb Ratio1.580-18%1.8591.8590%2.182-15%1.952-5%4.674-60%
Pe Ratio109.614-18%128.926128.9260%140.064-8%67.814+90%76.110+69%
Price Per Share5.960-18%7.0107.0100%8.240-15%7.078-1%8.875-21%
Price To Free Cash Flow Ratio-152.336+15%-179.174-179.1740%-104.861-41%-42.986-76%40.951-538%
Price To Total Gains Ratio51.664-18%60.76660.7660%42.343+44%31.152+95%5.834+942%
Quick Ratio--0.2530.2530%0.339-25%0.399-37%0.368-31%
Return On Assets--0.0100.0100%0.012-12%0.053-80%0.047-77%
Return On Equity--0.0140.0140%0.016-7%0.066-78%0.061-76%
Total Gains Per Share--0.1150.1150%0.195-41%0.295-61%0.455-75%
Usd Book Value--842478242.016842478242.0160%843679908.5940%805523075.145+5%641454631.759+31%
Usd Book Value Change Per Share---0.001-0.0010%0.022-103%0.017-104%0.046-102%
Usd Book Value Per Share--0.5200.5200%0.5210%0.498+5%0.396+31%
Usd Dividend Per Share--0.0170.0170%0.005+266%0.024-31%0.017-2%
Usd Eps--0.0080.0080%0.008-8%0.032-77%0.026-71%
Usd Free Cash Flow---8739670.388-8739670.3880%-17553511.118+101%34681712.089-125%23221829.641-138%
Usd Free Cash Flow Per Share---0.005-0.0050%-0.011+101%0.021-125%0.014-138%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%-0.004-75%-0.010-35%0.011-239%
Usd Market Cap1331364825.600-18%1565917353.6001565917353.6000%1840678886.400-15%1581119928.842-1%1982764111.521-21%
Usd Price Per Share0.822-18%0.9670.9670%1.137-15%0.977-1%1.225-21%
Usd Profit--12145894.60612145894.6060%13141684.830-8%51853350.439-77%41621989.360-71%
Usd Revenue--373171878.355373171878.3550%342906324.317+9%367642506.658+2%317217722.027+18%
Usd Total Gains Per Share--0.0160.0160%0.027-41%0.041-61%0.063-75%
 EOD+3 -5MRQTTM+0 -0YOY+11 -245Y+8 -2710Y+11 -25

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15109.614
Price to Book Ratio (EOD)Between0-11.580
Net Profit Margin (MRQ)Greater than00.033
Operating Margin (MRQ)Greater than00.033
Quick Ratio (MRQ)Greater than10.253
Current Ratio (MRQ)Greater than11.647
Debt to Asset Ratio (MRQ)Less than10.273
Debt to Equity Ratio (MRQ)Less than10.375
Return on Equity (MRQ)Greater than0.150.014
Return on Assets (MRQ)Greater than0.050.010
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.840
Ma 20Greater thanMa 505.694
Ma 50Greater thanMa 1005.548
Ma 100Greater thanMa 2006.058
OpenGreater thanClose5.740
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Other Stockholders Equity  -52-1,438-1,490152-1,339-299-1,6374,2242,586
Net Interest Income  68624,42025,106-6,50118,605-8,52610,079-15,553-5,474



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,393,100
Total Liabilities2,288,185
Total Stockholder Equity6,107,979
 As reported
Total Liabilities 2,288,185
Total Stockholder Equity+ 6,107,979
Total Assets = 8,393,100

Assets

Total Assets8,393,100
Total Current Assets3,245,690
Long-term Assets5,147,409
Total Current Assets
Cash And Cash Equivalents 1,490,816
Net Receivables 498,878
Inventory 1,102,442
Other Current Assets 68,152
Total Current Assets  (as reported)3,245,690
Total Current Assets  (calculated)3,160,288
+/- 85,403
Long-term Assets
Property Plant Equipment 3,097,547
Goodwill 711,006
Intangible Assets 555,762
Other Assets 62,213
Long-term Assets  (as reported)5,147,409
Long-term Assets  (calculated)4,426,528
+/- 720,881

Liabilities & Shareholders' Equity

Total Current Liabilities1,970,677
Long-term Liabilities317,508
Total Stockholder Equity6,107,979
Total Current Liabilities
Short Long Term Debt 832,461
Accounts payable 995,041
Other Current Liabilities 54,269
Total Current Liabilities  (as reported)1,970,677
Total Current Liabilities  (calculated)1,881,771
+/- 88,906
Long-term Liabilities
Long term Debt 148,136
Capital Lease Obligations Min Short Term Debt14,014
Other Liabilities 155,359
Long-term Liabilities Other 1,333
Deferred Long Term Liability 2,061
Long-term Liabilities  (as reported)317,508
Long-term Liabilities  (calculated)320,903
+/- 3,395
Total Stockholder Equity
Common Stock1,618,715
Retained Earnings 1,580,398
Other Stockholders Equity 2,586
Total Stockholder Equity (as reported)6,107,979
Total Stockholder Equity (calculated)3,201,700
+/- 2,906,279
Other
Capital Stock1,618,715
Common Stock Shares Outstanding 1,618,715
Net Invested Capital 7,088,576
Net Tangible Assets 4,841,211
Net Working Capital 1,275,014
Property Plant and Equipment Gross 3,097,547



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
362,384
387,376
576,717
921,934
949,753
1,013,074
996,269
1,140,319
1,435,135
1,918,019
2,109,537
4,167,443
4,830,763
6,905,599
7,466,927
7,035,373
6,747,199
7,178,568
8,019,943
8,393,100
8,393,1008,019,9437,178,5686,747,1997,035,3737,466,9276,905,5994,830,7634,167,4432,109,5371,918,0191,435,1351,140,319996,2691,013,074949,753921,934576,717387,376362,384
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
1,900,239
4,049,105
4,535,508
3,733,595
3,062,430
3,239,862
3,436,923
3,245,690
3,245,6903,436,9233,239,8623,062,4303,733,5954,535,5084,049,1051,900,239000000000000
       Cash And Cash Equivalents 
41,512
54,933
63,708
302,212
181,974
131,668
123,424
129,103
157,662
194,603
167,936
362,222
727,923
2,819,497
2,977,919
1,956,089
1,556,575
1,969,699
1,827,930
1,490,816
1,490,8161,827,9301,969,6991,556,5751,956,0892,977,9192,819,497727,923362,222167,936194,603157,662129,103123,424131,668181,974302,21263,70854,93341,512
       Short-term Investments 
4,671
576
800
500
0
0
0
0
561
0
0
120
0
0
50,000
150,000
0
0
9,481
0
09,48100150,00050,000001200056100005008005764,671
       Net Receivables 
118,409
74,867
111,090
98,553
185,754
182,387
220,903
209,618
216,089
208,618
252,892
348,243
418,372
554,433
610,284
597,755
552,611
405,702
577,543
498,878
498,878577,543405,702552,611597,755610,284554,433418,372348,243252,892208,618216,089209,618220,903182,387185,75498,553111,09074,867118,409
       Other Current Assets 
13,360
18,778
40,711
18,553
30,677
7,453
11,552
53,817
163,344
157,623
176,184
53,700
61,157
43,167
87,985
274,333
110,258
85,710
114,001
68,152
68,152114,00185,710110,258274,33387,98543,16761,15753,700176,184157,623163,34453,81711,5527,45330,67718,55340,71118,77813,360
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,856,494
2,931,420
3,301,778
3,684,769
3,938,707
4,583,020
5,147,409
5,147,4094,583,0203,938,7073,684,7693,301,7782,931,4202,856,4940000000000000
       Property Plant Equipment 
118,344
134,513
179,499
318,929
351,425
422,007
420,977
478,593
565,303
970,472
1,165,876
1,474,086
1,537,575
1,310,352
1,475,521
1,889,454
2,285,082
2,561,568
2,981,208
3,097,547
3,097,5472,981,2082,561,5682,285,0821,889,4541,475,5211,310,3521,537,5751,474,0861,165,876970,472565,303478,593420,977422,007351,425318,929179,499134,513118,344
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
711,006
711,006757,737757,737757,737757,737757,737757,737757,737757,73700000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
24,305
201,046
81,094
67,888
67,879
0
0
0
00067,87967,88881,094201,04624,305000000000000
       Intangible Assets 
4,946
3,877
0
19,882
50,312
49,218
48,073
46,968
11,536
20,448
0
1,223,377
502,173
433,731
538,859
539,515
533,455
517,876
490,128
555,762
555,762490,128517,876533,455539,515538,859433,731502,1731,223,377020,44811,53646,96848,07349,21850,31219,88203,8774,946
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
110,770
36,901
516
450
0
30,881
0
030,881045051636,901110,7700000000000000
> Total Liabilities 
277,357
255,348
393,757
402,665
411,694
465,577
434,481
502,281
698,173
1,179,973
1,476,738
988,734
1,258,017
2,135,260
2,324,919
1,644,823
1,022,737
1,326,499
1,906,321
2,288,185
2,288,1851,906,3211,326,4991,022,7371,644,8232,324,9192,135,2601,258,017988,7341,476,7381,179,973698,173502,281434,481465,577411,694402,665393,757255,348277,357
   > Total Current Liabilities 
205,632
217,348
386,190
400,260
411,694
465,554
403,802
424,181
537,938
682,615
977,071
866,421
1,041,074
1,753,955
2,184,758
1,579,026
940,282
1,181,754
1,732,690
1,970,677
1,970,6771,732,6901,181,754940,2821,579,0262,184,7581,753,9551,041,074866,421977,071682,615537,938424,181403,802465,554411,694400,260386,190217,348205,632
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
752,000
1,343,000
598,700
200,267
0
0
0
000200,267598,7001,343,000752,0000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
752,000
1,343,000
598,700
200,267
430,438
570,583
832,461
832,461570,583430,438200,267598,7001,343,000752,0000000000000000
       Accounts payable 
58,289
42,709
137,220
124,737
174,209
211,045
176,291
225,090
241,514
378,492
396,740
401,443
286,492
372,584
733,156
791,915
601,747
613,250
1,028,759
995,041
995,0411,028,759613,250601,747791,915733,156372,584286,492401,443396,740378,492241,514225,090176,291211,045174,209124,737137,22042,70958,289
       Other Current Liabilities 
35,793
26,282
22,750
26,571
6,025
0
17,200
42,070
41,398
58,182
84,194
158,601
75,465
59,120
44,298
120,528
61,698
39,829
39,940
54,269
54,26939,94039,82961,698120,52844,29859,12075,465158,60184,19458,18241,39842,07017,20006,02526,57122,75026,28235,793
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
381,305
140,161
65,797
82,455
144,745
173,631
317,508
317,508173,631144,74582,45565,797140,161381,3050000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-752,000
-1,343,000
-598,700
-200,267
22,045
17,822
14,014
14,01417,82222,045-200,267-598,700-1,343,000-752,0000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,333
1,333
12,971
1,333
2,333
1,333
1,333
1,3331,3332,3331,33312,9711,3331,3330000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,842
1,619
1,395
2,519
2,061
2,0612,5191,3951,6191,842000000000000000
> Total Stockholder Equity
81,915
128,763
181,049
516,686
535,076
544,623
558,875
634,885
728,829
711,722
623,112
3,184,357
3,585,545
4,767,697
5,142,008
5,390,550
5,724,462
5,852,086
6,115,001
6,107,979
6,107,9796,115,0015,852,0865,724,4625,390,5505,142,0084,767,6973,585,5453,184,357623,112711,722728,829634,885558,875544,623535,076516,686181,049128,76381,915
   Common Stock
30,000
80,000
80,000
107,000
160,500
160,500
160,500
160,500
161,463
324,490
324,490
723,044
759,759
1,622,767
1,621,610
1,618,820
1,618,715
1,618,715
1,618,715
1,618,715
1,618,7151,618,7151,618,7151,618,7151,618,8201,621,6101,622,767759,759723,044324,490324,490161,463160,500160,500160,500160,500107,00080,00080,00030,000
   Retained Earnings 
39,018
31,614
73,676
110,441
128,847
136,254
147,449
208,482
278,951
250,929
168,822
259,084
624,120
697,234
991,035
1,434,294
1,738,398
1,591,401
1,654,256
1,580,398
1,580,3981,654,2561,591,4011,738,3981,434,294991,035697,234624,120259,084168,822250,929278,951208,482147,449136,254128,847110,44173,67631,61439,018
   Capital Surplus 00000000000000000000
   Treasury Stock00000-100,403-152,278-173,468000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
96
-78
-68
-52
-1,490
-1,339
-1,637
2,586
2,586-1,637-1,339-1,490-52-68-7896000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,309,679
Cost of Revenue-1,873,403
Gross Profit436,276436,276
 
Operating Income (+$)
Gross Profit436,276
Operating Expense-2,331,582
Operating Income-21,903-1,895,306
 
Operating Expense (+$)
Research Development132,613
Selling General Administrative24,220
Selling And Marketing Expenses-
Operating Expense2,331,582156,833
 
Net Interest Income (+$)
Interest Income4,847
Interest Expense-39,177
Other Finance Cost-57,635
Net Interest Income-91,965
 
Pretax Income (+$)
Operating Income-21,903
Net Interest Income-91,965
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-180,826-21,903
EBIT - interestExpense = -39,177
-157,690
-118,513
Interest Expense39,177
Earnings Before Interest and Taxes (EBIT)--141,649
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-180,826
Tax Provision--21,503
Net Income From Continuing Ops-159,323-159,323
Net Income-157,690
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-91,965
 

Technical Analysis of Hisoar
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hisoar. The general trend of Hisoar is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hisoar's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Hisoar Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.29 < 6.5 < 6.5703.

The bearish price targets are: 5.05 > 3.91.

Tweet this
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Hisoar Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current macd is 0.000014.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hisoar price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hisoar. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hisoar price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current adx is 14.75.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hisoar shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Hisoar Pharmaceutical Co Ltd. The current sar is 5.0646.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current rsi is 57.84. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Hisoar Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hisoar price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current cci is 69.52.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current cmo is 24.21.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Hisoar Pharmaceutical Co Ltd. The current willr is -26.01626016.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hisoar is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Hisoar Pharmaceutical Co Ltd.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current atr is 0.25035572.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current obv is 494,459,171.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current mfi is 33.44.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Hisoar Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.840
Ma 20Greater thanMa 505.694
Ma 50Greater thanMa 1005.548
Ma 100Greater thanMa 2006.058
OpenGreater thanClose5.740
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hisoar with someone you think should read this too:
  • Are you bullish or bearish on Hisoar? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hisoar? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Hisoar Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisoar Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Hisoar Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Hisoar Pharmaceutical Co Ltd in your mailbox!